MEDICA 2022 and COMPAMED 2022 Witness Notable Increase in Participation and Booked Areas
By LabMedica International staff writers Posted on 13 Nov 2022 |

The international leading medical trade fair MEDICA (Düsseldorf, Germany), and COMPAMED, the leading international trade fair for suppliers from the medical technology industry, are being held in Düsseldorf, Germany from Monday to Thursday (14 to 17 November 2022). Compared to last year, when the first in-person event re-launched after the wholly digital meeting in 2020, both events have seen a notable increase in participation and booked presentation areas. Almost the entire trade fair area has been taken.
Both events combined are once again offering a professional audience a comprehensive overview of the newest medical products and services for modern treatment in doctors’ offices and clinics, including all relevant process steps in product development and product manufacturing. The scope of novelties being presented at MEDICA ranges from laboratory technology and equipment to physiotherapy and orthopedic technology, convenience goods and consumables, up to high-tech medical solutions (i.e. diagnostic imaging, robotics) and health IT applications.
Microengineering, innovative coatings and materials, sensors, packaging technology or complete processing of individual orders, too, are part of the main focus of COMPAMED in Halls 8a and 8b. The International Microtechnology Business Network IVAM will be organizing the COMPAMED HIGH-TECH FORUM as well as a product market geared towards microtechnology as part of COMPAMED. The goal of the session for internationalization “Europe meets USA – High-Tech for Medical Devices” is to strengthen the cooperation between players from component manufacture, device manufacture and users from Europe and the U.S. An evolving trend among suppliers which has been favored by the COVID-19 pandemic is microfluidics as a key technology for patient-centered applications of laboratory diagnostics.
Apart from this product area involving so-called “point-of-care” diagnostics, the pandemic has also given a certain “booster” to the digitalization of the health care system in many countries. This is where the digitally driven start-up scene profits, which offers many options to present themselves to investors and a professional medical audience. Of special note is the MEDICA START-UP PARK (in Hall 12), for example. The shared booth has established itself over the years as a central meeting point for business and networking, and this year, it again counts around 40 participants. One of them is the German start-up Thericon which sees itself as the first company to give operating theatres a type of imaging that has been compiled and visually assembled from several different sources. Visual representations of hitherto invisible tissue properties are presented together with standard colored images on a single monitor. This diagnostic information and its intuitive display aim to make faster and more precise surgical results possible. The company’s MEDICA START-UP PARK presentation explains how it works in detail. The scope of further news from start-ups stretches from a compact system for wireless monitoring of a fetus, new ophthalmoscopes as diagnostic aids for cancer or stroke, to a variety of solutions involving Artificial Intelligence (AI), for example for medical management of nutrition, creating electronic patient files, or even for pre-operative tests concerning the evaluation of cognitive disturbances.
Another special stage for start-ups is the MEDICA CONNECTED HEALTHCARE FORUM (also in Hall 12). The topics for the four-day forum program focus on applications for medical networks, on the health metaverse (VR/AR technologies), on AI and Big Data and also on robotics. Around a 100 chosen young companies will present their businesses on the forum stage, where the finals of the 11th MEDICA Start-up COMPETITION (14 Nov.) and the 14th Healthcare Innovation World Cup (13 Nov) will be among the highlights. A new addition to the MEDICA program in the midst of the physiotherapy themed segment is the MEDICA SPORTS HUB (in trade fair Hall 4). Throughout the duration of the trade fair, the professional audience is being invited to train and engage in a dialogue with some of the most successful Olympic athletes in German history: Heike Henkel (Olympic champion, world champion and world record holder in the high jump) and Lars Riedel (Olympic champion and multiple world champion in the discus). Short lectures by the Olympic athletes, talk sessions and also audience-participation sporting exercises have been planned to alternate every half hour on each day of the fair. The topics range from mental health, nutrition, team success to professional endurance training or even aspects of workplace health promotion.
Not only sports celebrities have announced their attendance at MEDICA 2022, the program of the forums and the parallel conferences also feature top-class speakers. For example, Federal Minister of Health Prof. Dr Karl Lauterbach will be taking part in the kick-off event of the 45th German Hospital Day (DKT), the annual leading event for the top management of German hospitals (14 Nov./CCD Ost). Stabilizing the financial situation of the public health insurers is one of the issues that will be addressed at the MEDICA ECON FORUM (in Hall 12), where Dr Andreas Gassen, Chairman of the National Association of Statutory Health Insurance Physicians (KBV) will also participate. The starting day (14 Nov.) will also offer exciting sessions, such as the one with Dr. Gottfried Ludewig, Senior Vice President T-Systems Health Industry, on the so-called "amazonisation" of the healthcare market by tech giants, including the question of the extent to which this development will also affect Germany. On the third day of the forum organized by Techniker Krankenkasse (16 Nov.), the North Rhine-Westphalian Minister for Labor, Health and Social Affairs, Karl-Josef Laumann, will be attending to address questions of future health policy in the Forum Dialogue. Also part of the MEDICA program will be the Conference on Disaster and Military Medicine DiMiMED and the MEDICA MEDICINE + SPORTS CONFERENCE for the international professional sports medicine and sports science scene.
“At MEDICA 2022, we will be welcoming more than 4,400 presenting companies. At COMPAMED 2022, there will be around 700. We consider this increase of 40% for booked areas and many different participants from 70 nations as a huge sign of the trust across borders that is being placed in both events,” said Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf, underscoring the importance of MEDICA and COMPAMED. “What the medical technology industry needs in turbulent times such as these are just these strong platforms for international exchange, joint ventures and business. Companies are seeing an increasing necessity to work jointly with their partners in supply and manufacturing to ensure delivery capacity in times when prices increase dramatically and construction parts are becoming sparse.”
Related Links:
MEDICA
Latest MEDICA 2022 News
- Bosch Demonstrates Vivalytic All-In-One PCR Analyzer at MEDICA 2022
- Biovendor Group Presents CLIA Solution for Complex Diagnostics at MEDICA 2022
- Diatron Exhibits Advanced Hematology and Clinical Chemistry Analyzers at MEDICA 2022
- Immundiagnostik AG Presents New PCR Test MutaPLEX RespiraScreen4_Diff_seqc at MEDICA 2022
- Eurotrol Presents the Future of Blood Gas Controls at MEDICA 2022
- Rhinomed Announces European Launch of Revolutionary New Swab for Testing Children for Respiratory Diseases
- Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes
- Cormay Diagnostics Introduces True 5+ DIFF Multi-Patented Hematology Solution at MEDICA 2022
- EDAN Takes its Solutions up a Notch at MEDICA 2022
- Bioneer Presents Near-Patient POC Molecular Diagnostic System at MEDICA 2022
- Rhinostics Features New RHINObot Automated Decapper at MEDICA 2022
- MP Biomedicals Exhibits Innovative POC, Screening and Confirmatory Tests at MEDICA 2022
- Oxford Immunotec Showcases Automated T-SPOT.TB Test at MEDICA 2022
- Boditech Highlights Automated Benchtop and Handheld Immunoassay Readers at MEDICA 2022
- Co-Diagnostics Introduces its CoPrimer Technology and Applications at MEDICA 2022
- Sentinel Diagnostics Presents New Fully Automated Sample to Result System for Diagnosis of Viral Infections
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
Genetic Test Could Predict Poor Outcomes in Lung Transplant Patients
Organ transplantation has dramatically transformed the management of patients suffering from organ failure. Yet, the immune system of the recipient often perceives the transplanted organ as a foreign entity,... Read more
Breakthrough Blood Test Enables Early Pancreatic Cancer Detection
Pancreatic cancer ranks as the fourth-leading cause of cancer-related deaths in the United States. At present, there are no molecular tools available for the early detection of this disease.... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more
Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more
Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more
POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read morePathology
view channel
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
Saliva is one of the most accessible biological fluids, yet it remains underutilized in clinical practice. While saliva samples are used to perform genetic tests to determine, for example, paternity, the... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more
Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more